Localized functional neurochemical marker abnormalities in dorsolateral prefrontal cortex in pediatric obsessive-compulsive disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 13, Issue SUPPL. 1, 2003, Pages

  Russell, Aileen ^a   Cortese, Bernadette ^a   Lorch, Elisa ^a   Ivey, Jennifer ^a   Banerjee, S Preeya ^a   Moore, Gregory J ^a   Rosenberg, David R ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Psychiatry 9B   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE DERIVATIVE; CREATINE; CREATINE PHOSPHATE; N ACETYLASPARTIC ACID;

ADOLESCENCE; ADOLESCENT; ARTICLE; BRAIN NERVE CELL; CELL HYPERPLASIA; CHILDHOOD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLIA CELL; HUMAN; HYPERTROPHY; HYPOPLASIA; MALE; NEUROBIOLOGY; NEUROCHEMISTRY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSESSIVE COMPULSIVE DISORDER; PATHOGENESIS; PHANTOM; PREFRONTAL CORTEX; SCHOOL CHILD; VALIDATION PROCESS;

ADOLESCENT; ASPARTIC ACID; BIOLOGICAL MARKERS; CHILD; CHOLINE; CREATINE; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; OBSESSIVE-COMPULSIVE DISORDER; PREFRONTAL CORTEX; PSYCHIATRIC STATUS RATING SCALES;

EID: 0038298305     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV). WA (DC), American Psychiatric Association, 1994.
2. Andreasen NC, Endicott J, Spitzer RL, Winokur G: The family history method using diagnostic criteria: Reliability and validity. Arch Gen Psychiatry 34:1229-1235, 1977.
3. 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects. Am J Psychiatry 155:1584-1591, 1998.
4. Baxter LR Jr, Phelps ME, Mazziotta JC, Guze BH, Schwartz JM, Selin CE: Local cerebral glucose metabolic rates in obsessive-compulsive disorder: A comparison with rates in unipolar depression and normal controls. Arch Gen Psychiatry 44: 211-218, 1987.
5. Baxter LR Jr, Schwartz JM, Bergman KS, Szuba MP, Guze BH, Mazziotta JC, Alazraki A, Selin CE, Ferng HK, Munford P, Phelps ME: Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 49:681-689, 1992.
6. Birken DL, Oldendorf WH: N-acetyl-aspartic-acid: A literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neurosci Biobehav Rev 13:23-31, 1989.
7. Brody AL, Saxena S, Schwartz JM, Stoessel PW, Maidment K, Phelps ME, Baxter LR Jr: FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder. Psychiatry Res 84:1-6, 1998.
8. Daniels DL, Haughton VM, Naidich TP: Cranial and Spinal Magnetic Resonance Imaging: An Atlas and Guide. New York, Raven Press, 1987.
9. Ebert D, Speck O, Konig A, Berger M, Henning J, Hohagen F: 1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: Evidence for neuronal loss in the cingulated gyrus and the right striatum. Psychiatry Res 74:173-176, 1997.
10. Eslinger PJ, Damasio AR: Severe disturbance of higher cognition after bilateral frontal lobe ablation: Patient EVR. Neurology 35:1731-1741, 1985.
11. Farchione TR, Moore GJ, Rosenberg DR: Proton magnetic resonance spectroscopic imaging in pediatric major depression. Biol Psychiatry 52: 86-92, 2002.
12. Fitzgerald KD, MacMaster FP, Paulson LD, Rosenberg DR: Neurobiology of childhood obsessive-compulsive disorder. Child Adolesc Psychiatr Clin N Am 8:533-575, 1999.
13. Fitzgerald KD, Moore GJ, Paulson LD, Stewart CM, Rosenberg DR: Proton spectroscopic imaging of the thalamus in treatment-naïve pediatric obsessive-compulsive disorder. Biol Psychiatry 47:174-182, 2000.
14. Gilbert AR, Moore GJ, Keshavan MS, Paulson LA, Narula V, Mac Master FP, Stewart CM, Rosenberg DR: Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine. Arch Gen Psychiatry 57: 449-456, 2000.
15. Gilbert AR, Rosenberg DR, Harenski K, Spencer S, Sweeney JA, Keshavan MS: Thalamic volume in pediatric patients with first-episode schizophrenia. Am J Psychiatry 158:618-624, 2001.
16. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS: The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 46:1006-1011, 1989.
17. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278-296, 1967.
18. Horwitz B, Swedo SE, Grady CL, Pietrini P, Schapiro MB, Rapoport JL, Rapoport SI: Cerebral metabolic pattern in obsessive-compulsive disorder: Altered intercorrelations between regional rates of glucose utilization. Psychiatry Res 40: 221-237, 1991.
19. Hugg JW, Maudsley AA, Weiner MW, Matson GB: Comparison of k-space sampling schemes for multidimensional MR spectroscopic imaging. Magn Reson Med 36:469-473, 1996.
20. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N: Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (KSADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980-988, 1997.
21. Kobak KA, Reynolds WM, Greist JH: Development and validation of a computer-administered version of the Hamilton Anxiety Scale. Psychol Assess 5:487-492, 1993.
22. Maier M, Ron MA, Barker GJ, Tofts PS. Proton magnetic resonance spectroscopy: An in vivo method of estimating hippocampal neuronal depletion in schizophrenia. Psychol Med 25:1201-1209, 1995.
23. Malloy P: Frontal lobe dysfunction in obsessive-compulsive disorder. In: The Frontal Lobes Revisited. Edited by Perceman E. New York, IRBN Press, 1987, pp 207-223.
24. Nauta WJ: The problem of the frontal lobe: A reinterpretation. J Psychiatr Res 8:167-187, 1971.
25. Nauta W: Connections of the frontal lobe with the limbic system. In: Surgical Approaches in Psychiatry. Edited by Laitinen LV, Livingston KE: Baltimore, University Park Press, 1973, pp 303-314.
26. Nolte J: Olfactory and limbic systems. In: The Human Brain: An Introduction to Its Functional Anatomy, 3rd ed. Edited by Farrell R. St. Louis, Mosby-Year Book Inc., 1993, pp 397-413.
27. Pauls DL, Alsobrook JP II, Goodman W, Rasmussen S, Leckman JF: A family study of obsessive-compulsive disorder. Am J Psychiatry 152:76-84, 1995.
28. Rajkowska G, Goldman-Rakic PS: Cyto-architectonic definition of prefrontal areas in the normal human cortex: II. Variability in locations of areas 9 and 46 and relationship to the Talairach Coordinate System. Cereb Cortex 5:323-337, 1995.
29. Rauch SL, Jenike MA, Alpert NM, Baer L, Breiter HC, Savage CR, Fischman AJ: Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry 51:62-70, 1994.
30. Rosenberg DR, Amponsah A, Sullivan A, MacMillan S, Moore GJ: Increased medial thalamic choline in pediatric obsessive-compulsive disorder as detected by quantitative in vivo spectroscopic imaging. J Child Neurol 16:636-641, 2001.
31. Rosenberg DR, Averbach DH, O'Hearn KM, Seymour AB, Birmaher B, Sweeney JA: Occulomotor response inhibition abnormalities in pediatric obsessive-compulsive disorder. Arch Gen Psychiatry 54:831-838, 1997.
32. Rosenberg DR, Keshavan MS: Toward a neuro-developmental model of obsessive-compulsive disorder. Biol Psychiatry 43:623-640, 1998.
33. Shrikhande A, Lorch E, Nolan C, Rosenberg DR: Assessment of delayed response in pediatric OCD patients. Biol Psychiatry 47(Suppl):151S, 2000.
34. Statistical Package for the Social Sciences (v9.0.1): Chicago, SPSS Inc., 1999.
35. Szeszko PR, Robinson D, Alvir JM, Bilder RM, Lenez T, Ashtari M: Orbital frontal and amygdala volume reductions in obsessive-compulsive disorder. Arch Gen Psychiatry 10:913-919, 1999.
36. Talairach J, Tournoux P: Co-Planar Stereotaxic Atlas of the Human Brain. New York, Thieme-Stratton Inc., 1988.
37. Tsai G, Coyle JT: N-acetylaspartate in neuropsychiatric disorders. Prog Neurobiol 46:531-540, 1995.
38. Urenjak J, Williams S, Gadian DG, Noble M: Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J Neurochem 59:55-561, 1992.
39. Vion-Dury J, Nicoli F, Salvan AM, Confort-Gouny S, Dhiver C, Cozzone PJ: Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy. Lancet 345:60-61, 1995.
40. Wolff RP, Wolff LS: Assessment and treatment of obsessive-compulsive disorder in children. Behav Modif 15:372-393, 1991.
41. Zald DH, Kim SW: Anatomy and function of the orbital frontal cortex, I: Anatomy, neurocircuitry, and obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci 8:125-138, 1996.